163 related articles for article (PubMed ID: 11418622)
1. Phosphatidylinositol 3-kinase is necessary but not sufficient for thrombopoietin-induced proliferation in engineered Mpl-bearing cell lines as well as in primary megakaryocytic progenitors.
Geddis AE; Fox NE; Kaushansky K
J Biol Chem; 2001 Sep; 276(37):34473-9. PubMed ID: 11418622
[TBL] [Abstract][Full Text] [Related]
2. Thrombopoietin-induced activation of the mitogen-activated protein kinase (MAPK) pathway in normal megakaryocytes: role in endomitosis.
Rojnuckarin P; Drachman JG; Kaushansky K
Blood; 1999 Aug; 94(4):1273-82. PubMed ID: 10438715
[TBL] [Abstract][Full Text] [Related]
3. Lnk inhibits Tpo-mpl signaling and Tpo-mediated megakaryocytopoiesis.
Tong W; Lodish HF
J Exp Med; 2004 Sep; 200(5):569-80. PubMed ID: 15337790
[TBL] [Abstract][Full Text] [Related]
4. A novel MPL point mutation resulting in thrombopoietin-independent activation.
Abe M; Suzuki K; Inagaki O; Sassa S; Shikama H
Leukemia; 2002 Aug; 16(8):1500-6. PubMed ID: 12145691
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous signalling through c-mpl, c-kit and CXCR4 enhances the proliferation and differentiation of human megakaryocyte progenitors: possible roles of the PI3-K, PKC and MAPK pathways.
Minamiguchi H; Kimura T; Urata Y; Miyazaki H; Bamba T; Abe T; Sonoda Y
Br J Haematol; 2001 Oct; 115(1):175-85. PubMed ID: 11722431
[TBL] [Abstract][Full Text] [Related]
6. Control of thrombopoietin-induced megakaryocytic differentiation by the mitogen-activated protein kinase pathway.
Rouyez MC; Boucheron C; Gisselbrecht S; Dusanter-Fourt I; Porteu F
Mol Cell Biol; 1997 Sep; 17(9):4991-5000. PubMed ID: 9271377
[TBL] [Abstract][Full Text] [Related]
7. Thrombopoietin (TPO) induces c-myc expression through a PI3K- and MAPK-dependent pathway that is not mediated by Akt, PKCzeta or mTOR in TPO-dependent cell lines and primary megakaryocytes.
Chanprasert S; Geddis AE; Barroga C; Fox NE; Kaushansky K
Cell Signal; 2006 Aug; 18(8):1212-8. PubMed ID: 16380230
[TBL] [Abstract][Full Text] [Related]
8. Lyn tyrosine kinase regulates thrombopoietin-induced proliferation of hematopoietic cell lines and primary megakaryocytic progenitors.
Lannutti BJ; Drachman JG
Blood; 2004 May; 103(10):3736-43. PubMed ID: 14726379
[TBL] [Abstract][Full Text] [Related]
9. Thrombopoietin induces phosphoinositol 3-kinase activation through SHP2, Gab, and insulin receptor substrate proteins in BAF3 cells and primary murine megakaryocytes.
Miyakawa Y; Rojnuckarin P; Habib T; Kaushansky K
J Biol Chem; 2001 Jan; 276(4):2494-502. PubMed ID: 11054408
[TBL] [Abstract][Full Text] [Related]
10. Effects of thrombopoietin, interleukin-3 and the kinase inhibitor K-252a on growth and polyploidization of the megakaryocytic cell line M-07e.
Quentmeier H; Zaborski M; Drexler HG
Leukemia; 1998 Oct; 12(10):1603-11. PubMed ID: 9766506
[TBL] [Abstract][Full Text] [Related]
11. Thrombopoietin-mediated sustained activation of extracellular signal-regulated kinase in UT7-Mpl cells requires both Ras-Raf-1- and Rap1-B-Raf-dependent pathways.
Garcia J; de Gunzburg J; Eychène A; Gisselbrecht S; Porteu F
Mol Cell Biol; 2001 Apr; 21(8):2659-70. PubMed ID: 11283246
[TBL] [Abstract][Full Text] [Related]
12. The c-Mpl ligand (thrombopoietin) stimulates tyrosine phosphorylation of Jak2, Shc, and c-Mpl.
Drachman JG; Griffin JD; Kaushansky K
J Biol Chem; 1995 Mar; 270(10):4979-82. PubMed ID: 7534285
[TBL] [Abstract][Full Text] [Related]
13. Differential signalling of NH2-terminal flag-labelled thrombopoietin receptor activated by TPO or anti-FLAG antibodies.
Millot GA; Vainchenker W; Duménil D; Svinarchuk F
Cell Signal; 2004 Mar; 16(3):355-63. PubMed ID: 14687665
[TBL] [Abstract][Full Text] [Related]
14. A thrombopoietin receptor mutant deficient in Jak-STAT activation mediates proliferation but not differentiation in UT-7 cells.
Dorsch M; Danial NN; Rothman PB; Goff SP
Blood; 1999 Oct; 94(8):2676-85. PubMed ID: 10515871
[TBL] [Abstract][Full Text] [Related]
15. Distinct effects of thrombopoietin depending on a threshold level of activated Mpl in BaF-3 cells.
Millot GA; Vainchenker W; Duménil D; Svinarchuk F
J Cell Sci; 2002 Jun; 115(Pt 11):2329-37. PubMed ID: 12006617
[TBL] [Abstract][Full Text] [Related]
16. Characterization of Mpl mutants using primary megakaryocyte-lineage cells from mpl(-/-) mice: a new system for Mpl structure-function studies.
Gaur M; Murphy GJ; deSauvage FJ; Leavitt AD
Blood; 2001 Mar; 97(6):1653-61. PubMed ID: 11238104
[TBL] [Abstract][Full Text] [Related]
17. Signaling by the Mpl receptor involves IKK and NF-kappaB.
Zhang Y; Sun S; Wang Z; Thompson A; Kaluzhny Y; Zimmet J; Ravid K
J Cell Biochem; 2002; 85(3):523-35. PubMed ID: 11967992
[TBL] [Abstract][Full Text] [Related]
18. A functional erythropoietin receptor is necessary for the action of thrombopoietin on erythroid cells lacking c-mpl.
Rouleau C; Cui K; Feldman L
Exp Hematol; 2004 Feb; 32(2):140-8. PubMed ID: 15102474
[TBL] [Abstract][Full Text] [Related]
19. Involvement of prolonged ras activation in thrombopoietin-induced megakaryocytic differentiation of a human factor-dependent hematopoietic cell line.
Matsumura I; Nakajima K; Wakao H; Hattori S; Hashimoto K; Sugahara H; Kato T; Miyazaki H; Hirano T; Kanakura Y
Mol Cell Biol; 1998 Jul; 18(7):4282-90. PubMed ID: 9632812
[TBL] [Abstract][Full Text] [Related]
20. Regulation of platelet activation in vitro by the c-Mpl ligand, thrombopoietin.
Chen J; Herceg-Harjacek L; Groopman JE; Grabarek J
Blood; 1995 Dec; 86(11):4054-62. PubMed ID: 7492761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
